Skip to main content
. 2021 Apr 29;17(4):357–380. doi: 10.1080/15592294.2021.1903376

Table 3.

Overview of genes examined in more than one candidate gene study on antidepressants

  NR3C1
Glucocorticoid receptor
SLC6A4
Serotonin transporter
BDNF
Brain-derived neurotrophic factor
FKBP5
Regulator of the glucocorticoid receptor
Galbally et al. (2020) [37] N.S.      
Mansell et al. (2016) [45] N.S.      
Gartstein et al. (2016) [38]   +    
Ciesielski et al. (2015) [33]       N.S.
Non et al. (2014) [32] N.S. N.S.
Devlin et al. (2010) [44]   N.S. N.S.  
Oberlander et al. (2008) [36] N.S.      
TOTAL STUDIES 4 3 2 2

‘+’: significantly increased DNAm level in medication-exposed group; ‘–’: significantly decreased DNAm level in medication-exposed group; ‘N.S.’: no significant difference between the medication-exposed and non-exposed groups.